Latest filing published 21 May 2024 for KalVista Pharmaceuticals, Inc., €88k.
Filing timeline
BuySaleInsider track record
Edward P. Feener: trading record in brief
Edward P. Feener (senior executive) discloses dealings in KalVista Pharmaceuticals, Inc. to SEC (Form 4). We count 54 filings; the first trade dates from 18 September 2018 and the latest from 20 May 2024.
On the market, this insider has only sold: 39 sales, €4.1M in total. Outside the open market, there are 4 share grants and 11 option exercises. In 2024 alone, the filings show no purchases and 8 sales.
The latest filing, published on 21 May 2024, reports an open-market sale of €88k in KalVista Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Edward P. Feener
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,088 shares@ US$11.761.9% of flowCommon StockSEC:0001415889-24-014007:1
- 18,789 sharesCommon StockSEC:0001415889-24-014007:0
- 8,397 shares@ US$14.112.4% of flowCommon StockSEC:0001415889-24-004718:1
- 19,591 shares@ US$14.045.6% of flowCommon StockSEC:0001415889-24-004718:2
- 300 shares@ US$14.720.1% of flowCommon StockSEC:0001415889-24-004718:3
- 18,788 sharesCommon StockSEC:0001415889-24-004718:0
- 28,171 shares@ US$15.009319.6% of flowCommon StockSEC:0001415889-24-004118:0
- 60,000 sharesCommon StockSEC:0001415889-24-003483:0
- 22,679 shares@ US$13.030313.3% of flowCommon StockSEC:0001209191-24-001515:0
- 100 shares@ US$13.000.0% of flowCommon StockSEC:0001209191-24-001391:1
- 17,221 shares@ US$13.007410.1% of flowCommon StockSEC:0001209191-24-001391:0
- 4,958 shares@ US$8.230.8% of flowCommon StockSEC:0001209191-23-056276:1
- 11,497 sharesCommon StockSEC:0001209191-23-056276:0
- 4,976 shares@ US$10.731.1% of flowCommon StockSEC:0001209191-23-046823:1
- 11,494 sharesCommon StockSEC:0001209191-23-046823:0
- 1,786 shares@ US$10.140.4% of flowCommon StockSEC:0001209191-23-031293:1
- 4,205 sharesCommon StockSEC:0001209191-23-031293:0
- 2,228 shares@ US$7.660.4% of flowCommon StockSEC:0001209191-23-012318:1
- 4,204 sharesCommon StockSEC:0001209191-23-012318:0
- 530 shares@ US$5.440.1% of flowCommon StockSEC:0001209191-22-058128:1
- 1,774 sharesCommon StockSEC:0001209191-22-058128:0
- 532 shares@ US$14.960.2% of flowCommon StockSEC:0001209191-22-046882:1
- 1,773 sharesCommon StockSEC:0001209191-22-046882:0
- 23,857 shares@ US$8.213.8% of flowCommon StockSEC:0001209191-22-002887:1
- 33,800 shares@ US$7.0710.5% of flowCommon StockSEC:0001209191-22-002887:0
25 of 54 declarations
